CHD | IS | CHD + IS | ||||
---|---|---|---|---|---|---|
HR | 95% CI | HR | 95% CI | HR | 95% CI | |
Men (n = 3743) | ||||||
Group II versus Group I | 1.13 | 0.93-1.37 | 1.40 | 1.06-1.85 | 1.20 | 1.01-1.42 |
2hPG-FPG (continuous) | 1.03 | 0.95-1.12 | 1.11 | 0.99-1.25 | 1.07 | 0.99-1.14 |
Women (n = 3916) | ||||||
Group II versus Group I | 1.33 | 0.83-2.12 | 0.94 | 0.59-1.50 | 1.10 | 0.79-1.54 |
2hPG-FPG (continuous) | 1.24 | 1.03-1.50 | 1.01 | 0.83-1.23 | 1.13 | 0.99-1.30 |
Total (n = 7659) | ||||||
Group II versus Group I | 1.15 | 0.97-1.38 | 1.27 | 1.00-1.62 | 1.18 | 1.02-1.37 |
2hPG-FPG (continuous) | 1.06 | 0.98-1.14 | 1.09 | 0.98-1.20 | 1.08 | 1.01-1.15 |